Nihon M&A Center Holdings Inc. Logo

Nihon M&A Center Holdings Inc.

M&A advisory firm specializing in brokerage and consulting for Japanese SMEs, including cross-border deals.

2127 | T

Overview

Corporate Details

ISIN(s):
JP3689050007
LEI:
Country:
Japan
Address:
千代田区丸の内一丁目8番2号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Nihon M&A Center Holdings Inc., established in 1991, is a leading mergers and acquisitions (M&A) advisory firm in Japan. The company specializes in providing comprehensive M&A brokerage and consulting services, with a primary focus on small and medium-sized enterprises (SMEs). It supports clients through the entire deal lifecycle, offering services such as M&A intermediation, corporate assessment and valuation, management buyout (MBO) support, and restructuring aid. In addition to its significant domestic presence, the firm facilitates cross-border M&A transactions, helping to integrate Japanese SMEs with the global economy.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-27 05:03
Post-Annual General Meeting Information
臨時報告書
Japanese 27.9 KB
2025-06-24 07:45
Regulatory News Service
内部統制報告書-第34期(2024/04/01-2025/03/31)
Japanese 24.9 KB
2025-06-24 07:45
Regulatory News Service
確認書
Japanese 8.9 KB
2025-06-24 07:44
Annual Report
有価証券報告書-第34期(2024/04/01-2025/03/31)
Japanese 2.0 MB
2024-11-14 08:09
Interim Report
確認書
Japanese 8.8 KB
2024-11-14 08:08
Interim Report
半期報告書-第34期(2024/04/01-2025/03/31)
Japanese 227.9 KB
2024-06-26 06:41
Post-Annual General Meeting Information
臨時報告書
Japanese 30.1 KB
2024-06-25 07:58
Annual Report
有価証券報告書-第33期(2023/04/01-2024/03/31)
Japanese 1.5 MB
2024-06-25 07:58
Governance Information
内部統制報告書-第33期(2023/04/01-2024/03/31)
Japanese 23.5 KB
2024-06-25 07:58
Registration Form
確認書
Japanese 8.8 KB
2024-06-17 09:10
Major Shareholding Notification
臨時報告書
Japanese 22.9 KB
2024-02-14 06:58
Quarterly Report
四半期報告書-第33期第3四半期(2023/10/01-2023/12/31)
Japanese 182.7 KB
2024-02-14 06:58
Report Publication Announcement
確認書
Japanese 8.8 KB
2023-11-14 07:02
Report Publication Announcement
確認書
Japanese 8.8 KB
2023-11-14 07:02
Quarterly Report
四半期報告書-第33期第2四半期(2023/04/01-2023/09/30)
Japanese 246.5 KB

Automate Your Workflow. Get a real-time feed of all Nihon M&A Center Holdings Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nihon M&A Center Holdings Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Nihon M&A Center Holdings Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Biotech R&D using a miniature pig model, offering CRO services and biomaterials to pharma.
South Korea 149300
Arterra Bioscience Logo
Develops natural active ingredients via biotechnology for cosmetic, pharma, and food sectors.
Italy ABS
ASUA Inc. Logo
Consulting and solutions provider enhancing logistics safety and efficiency with IoT and telecom.
Japan 246A
Licenses patented material IP (MST®) to create higher-performance, lower-power semiconductors.
United States of America ATOM
Atrae, Inc. Logo
Develops People Tech solutions for HR, including big data job sites and organizational analytics.
Japan 6194
Developing uranium and battery minerals for the nuclear energy and energy storage markets.
Australia N/A
BayCurrent, Inc. Logo
Comprehensive consulting on strategy, AI, and digital transformation for corporations and government.
Japan 6532
BenevolentAI Logo
An AI-powered drug discovery platform accelerating R&D for scientists and pharmaceutical partners.
United Kingdom BAI
BerGenBio Logo
Develops first-in-class AXL kinase inhibitors for cancer and severe respiratory infections.
Norway BGBIO
Bergman & Beving Logo
Acquires and develops niche companies with solutions for the industrial and construction sectors.
Sweden BERG

Talk to a Data Expert

Have a question? We'll get back to you promptly.